ProPhase Labs (PRPH) Equity Income (2026)
ProPhase Labs' Equity Income was -$47,000 in Q2 2026.
Powered by 
Analysis
ProPhase Labs (PRPH) Equity Income (2026) Analysis & Trends
For FY2025, Equity Income at ProPhase Labs came in at -$166,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | ProPhase Labs | 120,537.60 | -425,462.40 | 226,000.00 | -47,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47,000.00 |
| Mar 31, 2026 | -225,000.00 |
API Access
ProPhase Labs Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();